Archive content
This information originally appeared on the previous EHA website. Links to other pages may be inactive.
In an article published in Science|Business, Prof. Ulrich Jäger, Chair of EHA’s European Affairs Committee and member of the BioMed Alliance Board of Directors, argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments. In Framework Programme 9, processes must be optimised and the budget boosted – to deliver for patients and the economy.
Last Updated on Tuesday 27 February 2018.